We lacked a positive control genotype that could support the power of our study to detect expected genetic effects for CAD; PCSK9 and LPA genotypes associated with CAD in AA were not genotyped and lacked proxy SNPs in our data. This evidence concerns the gene PCSK9 and coronary artery disorder.